News Daily News No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits Michael O'Riordan July 14, 2025
News Daily News Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis Michael O'Riordan July 03, 2025
News Industry News Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels June 12, 2025
News Daily News Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years Yael L. Maxwell June 09, 2025
News Daily News Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI L.A. McKeown June 05, 2025
News Daily News Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION Michael O'Riordan June 04, 2025
News Conference News EuroPCR 2025 Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS L.A. McKeown May 30, 2025
News Daily News Pressure-Based Physiological Testing Results Diverge Between LAD, LCx Caitlin E. Cox May 29, 2025
News Conference News EuroPCR 2025 Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT Yael L. Maxwell May 23, 2025
News Conference News EuroPCR 2025 Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI L.A. McKeown May 22, 2025
News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Daily News Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA Yael L. Maxwell May 15, 2025
News Conference News ACC 2025 WARRIOR: No Clear Answers on How to Best Treat INOCA Yael L. Maxwell March 29, 2025
News Daily News ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients Michael O'Riordan March 26, 2025
News Daily News The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis Yael L. Maxwell March 24, 2025
News Daily News ACC Releases ‘Concise Clinical Guidance’ for Cardiogenic Shock Care Caitlin E. Cox March 19, 2025
News Daily News REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF Michael O'Riordan March 11, 2025
News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025